Chapter 9 - Nanoparticles influence pathophysiology of spinal cord injury and repair.
Sharma
Hari Shanker
HS
Laboratory of Cerebrovascular and Pain Research, Department of Surgical Sciences, Anesthesiology and Intensive Care Medicine, University Hospital, Uppsala University, SE-75185 Uppsala, Sweden. Sharma@surgsci.uu.se
Muresanu
Dafin F
DF
Sharma
Aruna
A
Patnaik
Ranjana
R
Lafuente
José Vicente
JV
D000818:Animals; D019610:Cytoprotection / Q000187:drug effects / Q000502:physiology; D016503:Drug Delivery Systems / Q000379:methods* / Q000639:trends; D006801:Humans; D053768:Metal Nanoparticles / Q000627:therapeutic use / Q000633:toxicity; D053758:Nanoparticles / Q000627:therapeutic use* / Q000633:toxicity; D036103:Nanotechnology / Q000379:methods* / Q000639:trends; D009410:Nerve Degeneration / Q000139:chemically induced / Q000503:physiopathology; D009462:Neurology / Q000379:methods* / Q000639:trends; D018696:Neuroprotective Agents / Q000008:administration & dosage; D018570:Risk Assessment; D013119:Spinal Cord Injuries / Q000188:drug therapy* / Q000503:physiopathology
D018696:Neuroprotective Agents